16-Sep-2024 12:55 AM CST - Business Insider Oppenheimer Sticks to Its Buy Rating for Dexcom (DXCM) In a report released today, Steven Lichtman from Oppenheimer maintained a Buy rating on Dexcom (DXCM - Research Report), with a price ... Wells Fargo also maintained a Buy rating on the stock with a $80.00 price target. Based on Dexcom's latest ...
15-Sep-2024 5:17 AM CST - Business Insider Wells Fargo Remains a Buy on Dexcom (DXCM) Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM - Research Report) on September 13 and set a price target of
12-Sep-2024 9:15 AM CST - YAHOO!Finance 3 Reasons DexCom Looks Like a No-Brainer Buy Right Now An exciting market opportunity for DexCom is to offer a solution for people who don't require insulin injections or even those who might not have diabetes, but who simply want to track their glucose levels to ensure they remain healthy. The company recently launched a product just for that: Stelo.
9-Sep-2024 6:39 PM CST - Business Insider DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom Investors and analysts reacted immediately to DexCom's revelation. The price of DexCom's common stock declined dramatically. From a closing market price of $107.85 per share on July 25, 2024, DexCom's stock price fell to $64.00 per share on July 26, 2024, a decline of about 40.66% in the span of just a single day.
16-Sep-2024 12:55 AM CST - Business Insider Oppenheimer Sticks to Its Buy Rating for Dexcom (DXCM) In a report released today, Steven Lichtman from Oppenheimer maintained a Buy rating on Dexcom (DXCM - Research Report), with a price ... Wells Fargo also maintained a Buy rating on the stock with a $80.00 price target. Based on Dexcom's latest ...
15-Sep-2024 5:17 AM CST - Business Insider Wells Fargo Remains a Buy on Dexcom (DXCM) Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM - Research Report) on September 13 and set a price target of
12-Sep-2024 9:15 AM CST - YAHOO!Finance 3 Reasons DexCom Looks Like a No-Brainer Buy Right Now An exciting market opportunity for DexCom is to offer a solution for people who don't require insulin injections or even those who might not have diabetes, but who simply want to track their glucose levels to ensure they remain healthy. The company recently launched a product just for that: Stelo.
9-Sep-2024 6:39 PM CST - Business Insider DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom Investors and analysts reacted immediately to DexCom's revelation. The price of DexCom's common stock declined dramatically. From a closing market price of $107.85 per share on July 25, 2024, DexCom's stock price fell to $64.00 per share on July 26, 2024, a decline of about 40.66% in the span of just a single day.
